Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Go Kamoshida"'
Autor:
Ryuichi Nakano, Akiyo Nakano, Ryuji Nishisouzu, Kenji Hikosaka, Yuki Suzuki, Go Kamoshida, Shigeru Tansho-Nagakawa, Shiro Endo, Kei Kasahara, Yasuo Ono, Hisakazu Yano
Publikováno v:
One Health, Vol 16, Iss , Pp 100524- (2023)
Objectives: The third-generation cephalosporin (3GC)-resistant E. coli strains have been detected worldwide in humans and animals. Hence, in this study, we evaluated the prevalence and genetic characteristics of 3GC-resistant E. coli in livestock, fa
Externí odkaz:
https://doaj.org/article/521d3a407a1448b3ba670e476ec4e1d8
Autor:
Ryuichi Nakano, Akiyo Nakano, Ryuji Nishisouzu, Kenji Hikosaka, Yuki Suzuki, Go Kamoshida, Tansho-Nagakawa Shigeru, Kei Kasahara, Yasuo Ono, Dr, Hisakazu Yano
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 31, Iss , Pp S25-S26 (2022)
Externí odkaz:
https://doaj.org/article/4708fbe5952f48e38a3fcc708b47bd0a
Autor:
Go Kamoshida, Noriteru Yamada, Tomoka Nakamura, Daiki Yamaguchi, Daichi Kai, Maho Yamashita, Chiaki Hayashi, Nana Kanda, Moe Sakaguchi, Hitoshi Morimoto, Teppei Sawada, Tomoko Okada, Yuki Kaya, Norihiko Takemoto, Kinnosuke Yahiro
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 5 (2022)
ABSTRACT Colistin, which targets lipopolysaccharide (LPS), is used as a last-resort drug against severe infections caused by drug-resistant Acinetobacter baumannii. However, A. baumannii possesses two colistin-resistance mechanisms. LPS modification
Externí odkaz:
https://doaj.org/article/3bbb1f6d404b441da29831f1a009ecf4
Autor:
SHIGERU TANSHO-NAGAKAWA, YOSHINORI SATO, TSUNEYUKI UBAGAI, TAKANE KIKUCHI-UEDA, GO KAMOSHIDA, SATOSHI NISHIDA, YASUO ONO
Publikováno v:
Polish Journal of Microbiology, Vol 70, Iss 4 (2021)
Externí odkaz:
https://doaj.org/article/c1933c59c18745aabc9a62d346c7b65e
Autor:
Go Kamoshida, Takuya Akaji, Norihiko Takemoto, Yusuke Suzuki, Yoshinori Sato, Daichi Kai, Taishi Hibino, Daiki Yamaguchi, Takane Kikuchi-Ueda, Satoshi Nishida, Yuka Unno, Shigeru Tansho-Nagakawa, Tsuneyuki Ubagai, Tohru Miyoshi-Akiyama, Masataka Oda, Yasuo Ono
Publikováno v:
Frontiers in Microbiology, Vol 11 (2020)
Acinetobacter baumannii causes nosocomial infections due to its multidrug resistance and high environmental adaptability. Colistin is a polypeptide antibacterial agent that targets lipopolysaccharide (LPS) and is currently used to control serious mul
Externí odkaz:
https://doaj.org/article/e3310e94d20f427993094c95b0fcdbbf
Publikováno v:
Pathogens, Vol 10, Iss 3, p 290 (2021)
Herein, we investigated the effect of bacterial lipooligosaccharides (LOS), from Acinetobacter baumannii, on the expression of pro-inflammatory genes that play an essential role in bacterial clearance. LAD2 human mast cells were stimulated with LOS d
Externí odkaz:
https://doaj.org/article/1a5ca8cf3f0f4b56b97a40d83277e2f2
Autor:
Atsushi Nakayama, Hideo Sato, Tenta Nakamura, Mai Hamada, Shuji Nagano, Shuhei Kameyama, Yui Furue, Naoki Hayashi, Go Kamoshida, Sangita Karanjit, Masataka Oda, Kosuke Namba
Publikováno v:
Marine Drugs, Vol 18, Iss 2, p 92 (2020)
Side-chain derivatives of eurotiumide A, a dihydroisochroman-type natural product, have been synthesized and their antimicrobial activities described. Sixteen derivatives were synthesized from a key intermediate of the total synthesis of eurotiumide
Externí odkaz:
https://doaj.org/article/29418da6412b417dae699a2c0a4e6107
Autor:
Go Kamoshida, Takane Kikuchi-Ueda, Satoshi Nishida, Shigeru Tansho-Nagakawa, Tsuneyuki Ubagai, Yasuo Ono
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Hospital-acquired infections caused by Acinetobacter baumannii have become problematic because of high rates of drug resistance. A. baumannii is usually harmless, but it may cause infectious diseases in an immunocompromised host. Although neutrophils
Externí odkaz:
https://doaj.org/article/0a095eb4623649ce9d33f89f14c21bcd
Autor:
Atsushi Yokotani, Fumi Takahashi, Ryoko Aoyama, Go Kamoshida, Tadashi Kosaka, Masaki Nakanishi, Naohisa Fujita
Publikováno v:
Microbiology and Immunology. 66:157-165
Bacillus cereus is an opportunistic pathogen that often causes severe infections such as bacteremia, with sphingomyelinase (SMase) being a crucial virulence factor. Although many strains of B. cereus carry the SMase gene, they are classified as SMase
Publikováno v:
Molecular Immunology. 129:39-44
Conventional antibiotics used for the treatment of severe infections such as sepsis and septic shock confer immunomodulatory benefits. However, the growing problem of multidrug resistant infections has led to an increase in the administration of non-